Skip to main content

Table 5 Frequency and percentage of clinical complications among solid organ transplant recipients regarding different therapeutic regimens during the hospitalization period

From: Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

Medications

Complication

Bacterial superinfection; n = 58

Elevated liver enzymes; n = 123

Reduced glomerular filtration rate; n = 31

Neutropenia or thrombocytopenia; n = 29

Cardiovascular; n = 67

Gastrointestinal; n = 93

Hydroxychloroquine

10 (17)

32 (26)

3 (10)

2 (7)

31 (46)

49 (53)

Interferon

11 (19)

24 (20)

2 (6)

1 (3)

–

1 (1)

Lopinavir/Ritonavir

9 (16)

41 (33)

4 (13)

2 (7)

30 (45)

22 (24)

Remdesivir

7 (12)

11 (9)

12 (39)

4 (14)

–

9 (10)

Tocilizumab

6 (10)

8 (7)

6 (19)

13 (45)

2 (3)

7 (8)

Dexamethasone or High dose methylprednisolone

15 (26)

7 (6)

4 (13)

7 (24)

4 (6)

5 (5)

P value

0.09

0.11

0.88

1.32

1.09

0.77